(2) Cash on March 31, 2021 equals $145.4 billion up from $138.3 billion on December 31, 2020.
(3) Stock buybacks equaled $6.6 billion at average price of $360,000 per A share (vs. current price of $412,500) down from $9 billion in Q4.
(4) Stock buybacks in Q2 through April 22 equaled at least $1.2 billion (if at Q1 price of $360,000 per A Share).
(5) Berkshire was a net seller of equities in the first quarter, reducing its stake in “Commercial, industrial, and other” by $2.6 billion on a cost basis. Berkshire sold a net $3.9 billion in equities last quarter, as it bought $2.6 billion of stock and sold $6.5 billion worth in the period.
(6) Berkshire’s book value on March 31 equaled $294,000 per share. Its price today ($412,500) to book value ratio equals 1.4 which is about average for Berkshire over many years.
David I Kass
Clinical Associate Professor, Department of Finance
Ph.D., Harvard University
Robert H. Smith School of Business
4412 Van Munching Hall
University of Maryland
College Park, MD 20742-1815
Phone: 301-405-9683
Email: [email protected] (link sends e-mail)
Dr. David Kass has published articles in corporate finance, industrial organization, and health economics. He currently teaches Advanced Financial Management and Business Finance, and is the Faculty Champion for the Accelerated Finance Fellows. Prior to joining the faculty of the Smith School in 2004, he held senior positions with the Federal Government (Federal Trade Commission, General Accounting Office, Department of Defense, and the Bureau of Economic Analysis). Dr. Kass has recently appeared on Bloomberg TV, CNBC, PBS Nightly Business Report, Maryland Public Television, Business News Network TV (Canada), Fox TV, American Public Media's Marketplace Radio, and WYPR Radio (Baltimore), and has been quoted on numerous occasions by Bloomberg News and The Wall Street Journal, where he has primarily discussed Warren Buffett and Berkshire Hathaway. He has also launched a Smith School “Warren Buffett” blog. Dr. Kass has accompanied MBA students on trips to Omaha for private meetings with Warren Buffett, and Finance Fellows to Berkshire Hathaway’s annual meetings. He is an officer of the Harvard Business School Club of Washington, DC, and is a member of the investment and budget committees of a local nonprofit organization. Dr. Kass received a Smith School “Top 15% Teaching Award” for the 2009-2010 academic year.
There are countless ways to evaluate equities, and they all have glaring flaws. Equity valuation is not a science with predictive formulas. It is subjective, and the formulas themselves... Read More
Quickly following Puerto Rican debt being thrown into bankruptcy after a settlement could not be reached, bond investors are looking to challenge the move in court. Argentina’s debt woes... Read More
The US Supreme today put a nail in Hank Greenberg’s crusade to hold the Federal Reserve Bank of New York responsible for unlawfully bailing out the insurer while engineering... Read More
When Barclays recently rolled out its new research pricing platform, which is priced at $455,000 per year for the "gold" package, it highlighted how material changes are befalling the... Read More
Longleaf Partners Fund commentary for the second quarter ended June 30, 2015.
Get The Full Series in PDF
Get the entire 10-part series on Charlie Munger in PDF. Save it to... Read More
Kenneth Griffin's Citadel Advisors LLC has increased its stake in LSI Corporation (NYSE:LSI), from 4.48% reported in June 29th, to 5.4%, according to the latest SEC form 13G filing.... Read More
As I reported last week, Citigroup Inc. (NYSE:C) is looking to sell the rest of its Smith Barney joint venture stake with Morgan Stanley (NYSE:MS). Morgan Stanley (NYSE:MS) has utilized its share... Read More
Norma Provencio, who currently leads Valeant Pharmaceuticals board’s audit committee, was previously a director of a publicly traded company that failed after the government cracked down on a half-decade... Read More
History will judge the Troubled Asset Relief Program more positively than people do now, Warren Buffett said on CNBC Thursday—five years to the day since the financial bailout program... Read More
S&P’s SPIVA scorecard provides persuasive evidence of the futility of active management. But its most recent scorecard illustrates something else – why active managers underperform even in the best... Read More
